BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2412067)

  • 1. The pentagastrin test in the diagnosis of the carcinoid syndrome.
    Ahlman H; Dahlström A; Grönstad K; Jaffe BM; Nilsson O; Oberg K
    J Cardiovasc Pharmacol; 1985; 7 Suppl 7():S86-8. PubMed ID: 2412067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pentagastrin test in the diagnosis of the carcinoid syndrome. Blockade of gastrointestinal symptoms by ketanserin.
    Ahlman H; Dahlström A; Grönstad K; Tisell LE; Oberg K; Zinner MJ; Jaffe BM
    Ann Surg; 1985 Jan; 201(1):81-6. PubMed ID: 2578277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma substance-P in neuroendocrine tumors and idiopathic flushing: the value of pentagastrin stimulation tests and the effects of somatostatin analog.
    Vinik AI; Gonin J; England BG; Jackson T; McLeod MK; Cho K
    J Clin Endocrinol Metab; 1990 Jun; 70(6):1702-9. PubMed ID: 1693375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On the mode of action of the pentagastrin test in the carcinoid syndrome.
    Grönstad KO; Nilsson O; Hedman I; Skolnik G; Dahlström A; Ahlman H
    Scand J Gastroenterol; 1985 May; 20(4):508-11. PubMed ID: 4023617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SMS 201-995 and provocation tests in preparation of patients with carcinoids for surgery or hepatic arterial embolization.
    Ahlman H; Ahlund L; Dahlström A; Martner J; Stenqvist O; Tylén U
    Anesth Analg; 1988 Dec; 67(12):1142-8. PubMed ID: 2461665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adrenergic control of serotonin release from a midgut carcinoid tumour.
    Nilsson O; Grönstad KO; Goldstein M; Skolnik G; Dahlström A; Ahlman H
    Int J Cancer; 1985 Sep; 36(3):307-12. PubMed ID: 2411674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serotonin and carcinoid tumors.
    Ahlman H
    J Cardiovasc Pharmacol; 1985; 7 Suppl 7():S79-85. PubMed ID: 2412066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gastrointestinal carcinoids: characterization by site of origin and hormone production.
    Onaitis MW; Kirshbom PM; Hayward TZ; Quayle FJ; Feldman JM; Seigler HF; Tyler DS
    Ann Surg; 2000 Oct; 232(4):549-56. PubMed ID: 10998653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carcinoids and carcinoid syndrome.
    Creutzfeldt W; Stöckmann F
    Am J Med; 1987 May; 82(5B):4-16. PubMed ID: 2884878
    [No Abstract]   [Full Text] [Related]  

  • 10. Serotonin release into blood after food and pentagastrin. Studies in healthy subjects and in patients with metastatic carcinoid tumors.
    Richter G; Stöckmann F; Conlon JM; Creutzfeldt W
    Gastroenterology; 1986 Sep; 91(3):612-8. PubMed ID: 2426155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pentagastrin test as an indicator of a cure in surgically treated patients with advanced carcinoid disease.
    Ahlman H; Nilsson O; Dahlström A; Tisell LE
    J Surg Oncol; 1988 May; 38(1):52-6. PubMed ID: 2453757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of octreotide on basal and stimulated hormone levels in patients with carcinoid syndrome.
    Oberg K; Norheim I; Theodorsson E; Ahlman H; Lundqvist G; Wide L
    J Clin Endocrinol Metab; 1989 Apr; 68(4):796-800. PubMed ID: 2466045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gastrointestinal carcinoids and the carcinoid syndrome: clinical characteristics and therapy.
    Crowder BL; Judd ES; Dockerty MB
    CA Cancer J Clin; 1968; 18(4):212-8. PubMed ID: 4992871
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of a long-acting somatostatin analogue (octreotide) on circulating tachykinins and the pentagastrin-induced carcinoid flush.
    Balks HJ; Conlon JM; Creutzfeldt W; Stöckmann F
    Eur J Clin Pharmacol; 1989; 36(2):133-7. PubMed ID: 2470592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastrointestinal carcinoids and the malignant carcinoid syndrome.
    Beaton H; Homan W; Dineen P
    Surg Gynecol Obstet; 1981 Mar; 152(3):268-72. PubMed ID: 7466571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Verapamil and diarrhoea in the carcinoid syndrome--clinical and experimental observations on serotonin release.
    Ahlman H; Nilsson O; Grönstad KO; Skolnik G; Tisell LE; Dahlström A
    Br J Cancer; 1986 Aug; 54(2):251-6. PubMed ID: 3741762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential actions of serotonin antagonists on two behavioral models of serotonin receptor activation in the rat.
    Lucki I; Nobler MS; Frazer A
    J Pharmacol Exp Ther; 1984 Jan; 228(1):133-9. PubMed ID: 6694097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flushing in the carcinoid syndrome and plasma kallikrein.
    Lucas KJ; Feldman JM
    Cancer; 1986 Nov; 58(10):2290-3. PubMed ID: 2428458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tachykinins in carcinoid tumors: their use as a tumor marker and possible role in the carcinoid flush.
    Norheim I; Theodorsson-Norheim E; Brodin E; Oberg K
    J Clin Endocrinol Metab; 1986 Sep; 63(3):605-12. PubMed ID: 2426299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A possible mechanism for the release of serotonin from the gut caused by pentagastrin.
    Grönstad KO; Ahlund L; Dahlström A; Häggendal J; Ahlman H
    J Surg Res; 1988 May; 44(5):473-8. PubMed ID: 3374113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.